top of page

HKU develops a light-controlled nanomedicine for precise drug delivery to treat colorectal cancer


Dr. Wang Weiping, Assistant Professor of Dr. Li Dak-Sum Research Centre and Department of Pharmacology and Pharmacy, HKUMed, and Principal Investigator of the State Key Laboratory of Pharmaceutical Biotechnology, HKU, (second from left, front row) and his research team.



A research team from Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (HKUMed), has developed a photo-responsive nanomedicine for light-controlled colorectal cancer therapy. The nanoparticles are simply made by self-assembly of a near-infrared dye and a prodrug. After intravenous injection, the nanoparticles can target colon tumours and release drugs to kill cancer cells upon light irradiation. This process can be in-situ monitored by in vivo imaging. The research has been published in Bioengineering & Translational Medicine (link to the publication), and a patent application has been filed based on this work.



Source:


Li Ka Shing Faculty of Medicine, The University of Hong Kong

Date: March 23, 2022

Topic: HKU develops a light-controlled nanomedicine for precise drug delivery to treat colorectal cancer



Relevant information can also be found in the following articles:



經濟通ET Net

Date: March 24, 2022

Topic: 癌症新療法│港大研發光控治大腸癌!釋放藥物更精準,減少身體其他部位有害副作用!



on.cc東網

Date: March 23, 2022

Topic: 港大研大腸癌光控療法 精確落藥瞄準腫瘤組織減低副作用



YAHOO! 新聞

Date: March 23, 2022

Topic: 癌症治療|港大開發新型結直腸癌光控療法 助瞄準腫瘤組織釋放藥物減副作用



HK01

Date: March 23, 2022

Topic: 港大研發大腸癌光控療法 助瞄準腫瘤組織釋放藥物殺死癌細胞



頭條⽇報

Date: March 23, 2022

Topic: 港大研發新型大腸癌光控療法 助降化療對其他部位副作用



LINE TODAY

Date: March 23, 2022

Topic: 港大研大腸癌光控療法 精確落藥瞄準腫瘤組織減低副作用



bottom of page